Lentigo maligna melanoma is a melanoma in situ on sun-damaged skin. It is a variably brown-pigmented flat patch on the head or neck of elderly patients. Its growth is generally slow, but it can ...

Reflectance confocal microscopy had a high negative predictive value and agreement when compared with histopathology for the presurgical margin mapping of lentigo maligna and lentigo maligna melanoma.

One of the largest studies of outcomes of treatments for LM reviewed 13,051 cases of melanoma in situ (Zalaudek et al., 2003), of which 95.9% were treated with excision and the remainder were ...

There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.

Experienced dermatologists using dermoscopy/dermoscopic images had 2.6-fold higher odds of accurate melanoma diagnosis than those who used clinical examination/images. Accuracy in diagnosing skin ...

The Breslow thickness describes how deep a melanoma has grown into the layers of skin. Doctors need to know the depth of a melanoma to help stage it. The stage tells you the size of a cancer and if it ...

Melanoma is the most serious type of skin cancer. It develops when skin cells multiply rapidly as a consequence of mutations in their DNA caused by UV exposure. Melanomas originate in the pigment ...

The number stage of a melanoma tells you how thick it is and whether it has spread. It also tells you whether the top layer of the melanoma looks broken (ulcerated) when looked at under a microscope.

Uveal melanoma is a type of cancer that develops in the middle layer of your eye called the uvea. It can cause symptoms like blurry vision, floaters, or loss of vision. Melanoma is a type of ...

Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2–Amplified Metastatic Colorectal Cancer: ...

Five-year recurrence-free survival was 55.1% with nevus-associated acral melanoma (NAAM) vs. 42.3% with de novo acral melanoma (DNAM). Overall 5-year survival was 75.1% vs. 63.2% in the NAAM vs.

1 Patients often present with advanced disease at the time of diagnosis and therefore have a worse prognosis when compared to other melanoma subtypes. 2 Dermoscopy of the lesions shows specific ...